Eligibility Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module

Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-24 @ 5:47 PM
NCT ID: NCT00435968
Eligibility Criteria: Inclusion Criteria: * General good health * Willing to adhere to the requirements of the protocol, including availability for follow-up visits * Willing and able to sign written informed consent Exclusion Criteria: * Individuals with known HIV infection * Individuals with malignancy * Individuals with a history or symptoms of unstable cardiovascular disease * Individuals with renal abnormalities * Individuals having a history or symptoms of pulmonary disease * Individuals having acute or active chronic liver disease * Individuals having neurologic or psychiatric disease * Individuals having active tuberculosis * Individuals having multiple sclerosis * Individuals having bleeding disorders * Individuals with planned surgery over the course of the trial or having had major surgery in the past 6 mo. * Individuals with a history of alcohol/drug abuse * Pregnant and lactating women * Individuals on prescribed medication with the exception of oral contraceptives * Individuals with Crohn's disease, Lupus, Rheumatoid arthritis, Colitis or any other auto-immune disease * Individuals using natural health products or dietary supplements for 2 weeks prior and during the trial * Individuals having allergies to ginseng or to any known component of the drug product or placebo * Smokers (smoking \> 10 cigarettes/day) * Alcoholics (drinking \> 10 drinks/week)
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT00435968
Study Brief:
Protocol Section: NCT00435968